A meta-analysis indicated that creatinine to Cystatin C Ratio (CCR) can be used to make up for the limitations of a single evaluation index, and can better reduce the influence of other factors on CKD (11), and can assess the occurrence of CKD more comprehensively. Here, CST3 is linked to chronic kidney disease.